3D Foot Scanner Reliability for Footwear Fit and Design
Launched by UNIVERSITY OF LEICESTER · Jan 4, 2023
Trial Information
Current as of May 15, 2025
Completed
Keywords
ClinConnect Summary
Evidence of reliability is essential for use of a 3D foot scanner in diabetes footwear fit evaluation and orthopaedic footwear design. The investigators will carry out a proof-of-concept study in 20 healthy adult male and female volunteers in order to: assess the 3D foot scanner's reliability. Specifically, the investigators will assess its variability during three repeated foot scans of the same subject's foot. Three half weightbearing foot scans will be carried out by two different examiners to measure intrarater and interrater reliability (Intraclass Correlation Coefficient).
The invest...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy men and women aged 18 years or over
- • Able to walk unaided
- • Able to walk up steps (the 3D scanner requires a small step on to the device to enter the correct position for measurement)
- • Willingness and capacity to participate in the study and to sign the informed consent form
- Exclusion Criteria:
- • Diabetes mellitus diagnosis
- • Inability to ambulate independently without walking aids
- • No obvious foot deformities
- • No history of foot surgery
- • No pain, injuries or medical conditions affecting the legs or lower back
- • Any issues around balance (participants must remain standing in position for the approximately fifteen seconds required to obtain the 3D scan of their feet)
- • Health conditions that impact foot morphology
About University Of Leicester
The University of Leicester is a leading research institution in the UK, renowned for its commitment to advancing scientific knowledge and improving healthcare through innovative clinical trials. The university fosters a collaborative environment that integrates diverse disciplines, enabling the development of cutting-edge research initiatives aimed at addressing pressing medical challenges. With a focus on ethical practices and patient-centered outcomes, the University of Leicester is dedicated to enhancing clinical research methodologies and contributing to the advancement of medical sciences, ultimately striving to translate research findings into tangible health benefits for communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leicester, , United Kingdom
Patients applied
Trial Officials
Petra J Jones
Principal Investigator
University Hospitals, Leicester
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials